Cargando…
Superoxide Dismutases in Pancreatic Cancer
The incidence of pancreatic cancer is increasing as the population ages but treatment advancements continue to lag far behind. The majority of pancreatic cancer patients have a K-ras oncogene mutation causing a shift in the redox state of the cell, favoring malignant proliferation. This mutation is...
Autores principales: | Wilkes, Justin G., Alexander, Matthew S., Cullen, Joseph J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618094/ https://www.ncbi.nlm.nih.gov/pubmed/28825637 http://dx.doi.org/10.3390/antiox6030066 |
Ejemplares similares
-
Superoxide Dismutases
and Superoxide Reductases
por: Sheng, Yuewei, et al.
Publicado: (2014) -
Therapeutic potentials of superoxide dismutase
por: Younus, H.
Publicado: (2018) -
The Role of Manganese Superoxide Dismutase in Skin Cancer
por: Robbins, Delira, et al.
Publicado: (2011) -
Manganese Superoxide Dismutase: Guardian of the Powerhouse
por: Holley, Aaron K., et al.
Publicado: (2011) -
On the Origin of Superoxide Dismutase: An Evolutionary Perspective of Superoxide-Mediated Redox Signaling
por: Case, Adam J.
Publicado: (2017)